Clinical Study of Divozilimab in Patients With Systemic Scleroderma

NCT05726630 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Scleroderma

Interventions

DRUG: Divozilimab
DRUG: Placebo

Sponsor

Biocad